Computational Chemistry, Molecular Complexity and Screening Set Design

Chemoinformatics in Drug Discovery

Volumn 23, Issue , 2005, Pages 43-57

  Hann, Michael M ^a   Leach, Andrew R ^a   Green, Darren V S ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

"leadlike" screening sets; Compound filters; Computational chemistry; Construction of high throughput screening sets; Molecular complexity; Screening set design

Indexed keywords

THROUGHPUT;

COMPOUND FILTERS; HIGH THROUGHPUT SCREENING; LEADLIKE SCREENING SETS; MOLECULAR COMPLEXITY; SET DESIGN;

COMPUTATIONAL CHEMISTRY;

EID: 84971487341     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527603743.ch3     Document Type: Chapter

References (22)

1. LIPINSKI, C.A., LOMBARDO, F., DOMINY, B.W., FEENEY, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997, 23, 3-25.
2. BOHACEK, R.S., MARTIN, C., GUIDA, W.C. The Art and Practice of Structure-Based Drug Design: A Molecular Modeling Perspective. Med. Res. Rev. 1996, 16, 3-50.
3. MARTIN, Y.C., KOFRON, J.L., TRAPHAGEN, L.M. Do structurally similar molecules have similar biological activity? J. Med. Chem. 2002, 45, 4350-4358.
4. MASON, J.S., MORIZE, I., MENARD, P.R., CHENEY, D.L., HULME, C., LABAUDINIERE, R.F. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. J. Med. Chem. 1999, 42(17), 3251-3264.
5. LEACH, A.R., GREEN, D.V.S., HANN, M.M., JUDD, D.B., GOOD, A.C. Where are the GaPs? A rational approach to monomer acquisition and selection. J. Chem. Inf. Comput. Sci. 2000, 40, 1262-1269.
6. HANN, M.M., HUDSON, B., LEWELL, X-Q., LIFELY, R., MILLER, L., RAMSDEN, N. Strategic pooling of compounds for high-throughput screening. J. Chem. Inf. Comput. Sci. 1999, 39, 897-902.
7. HANN, M.M., LEACH, A.R., HARPER, G. Molecular complexity and its impact on the probability of finding leads for drug discovery. J. Chem. Inf. Comput. Sci. 2001, 41, 856-864.
8. HAJDUK, P.J., BURES, M., PRAESTGAARD, J., FESIK, S.W. Privileged molecules for protein binding identified from NMR-based screening. J. Med. Chem. 2000, 43, 3443-3447.
9. OPREA, T.I., DAVIS, A.M., TEAGUE, S.J., LEESON, P.D. Is there a difference between leads and drugs? A historical perspective. J. Chem. Inf. Comput. Sci. 2001, 41, 1308-1315.
10. ERLANSON, D.A., BRAISTED, A.C., RAPHAEL, D.R., RANDAL, M., STROUD, R.M., GORDON, E.M., WELLS, J.A. Site-directed ligand discovery. Proc. Nat. Acad. Sci. U.S.A. 2000, 97, 9367-9372.
11. CARR, R. JHOTI, H. Structure-based screening of low-affinity compounds. Drug Disc. Today 2002, 7, 522-527.
12. GILLET, V.J., WILLETT, P., BRADSHAW, J. Identification of biological activity profiles using substructural analysis and genetic algorithms. J. Chem. Inf. Comput. Sci. 1998, 38, 165-179.
13. SADOWSKI, J. KUBINYI, H. A scoring scheme for discriminating between drugs and nondrugs. J. Med. Chem. 1998, 41, 3325-3329.
14. SNEADER, W. Drug Prototypes and their Exploitation. John Wiley & Sons, Chichester and New York, 1996.
15. ALEXANDER, A. Unpublished observations. PDB files are: 6TMN and 5TMN.
16. BARTLETT, P.A. MARLOWE, C.K. Evaluation of intrinsic binding energy from a hydrogen bonding group in an enzyme inhibitor. Science 1987, 235, 569-571.
17. MERZ, K.M., Jr., KOLLMAN, P.A. Free energy perturbation simulations of the inhibition of thermolysin: prediction of the free energy of binding of a new inhibitor. J. Am. Chem. Soc. 1989, 111, 5649-5658.
18. DAVIS, A.M., TEAGUE, S.J., KLEYWEGT, G.J. Application and limitations of X-ray crystallographic data in structure-based ligand and drug design. Angew. Chemie. Int. Ed. 2003, 42, 2718-2736.
19. BRADSHAW, J. D. LANGLEY. More fun with chemical catalogues. Talk at EuroMUG Meeting, 1999. See http://www.daylight.com/meetings/mug99/Bradshaw/Presentation.html
20. Catalyst. Accelrys Inc. 9685 Scranton Road, San Diego, CA 92121-3752, USA.
21. LEWELL, X-Q., JUDD, D.B., WATSON, S.P., HANN, M.M. RECAP-retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J. Chem. Inf. Comput. Sci. 1998, 38, 511-522.
22. HANN, M.M.OPREA, T.I. Pursuing the leadlikeness concept in pharmaceutical research. Curr. Opin. Chem. Biol. 2004, 8, 255-263.